Cargando…
Update on the use of fibrates: focus on bezafibrate
Low-density lipoprotein-cholesterol (LDL-C) is a well established coronary heart disease (CHD) risk factor. However, the ability of this metabolic risk factor alone to identify individuals at rigk for future CHD events is limited. The raised triglycerides-low high-density lipoprotein-cholesterol (HD...
Autores principales: | Goldenberg, Ilan, Benderly, Michal, Goldbourt, Uri |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2464751/ https://www.ncbi.nlm.nih.gov/pubmed/18629356 |
Ejemplares similares
-
Lagrangian Fibrations
por: Huybrechts, D., et al.
Publicado: (2022) -
Classifying spaces and fibrations
por: May, J Peter
Publicado: (1975) -
Fibrations in CICY Threefolds
por: Anderson, Lara B., et al.
Publicado: (2017) -
Cessation of Bezafibrate in patients with chronic kidney disease improves renal function
por: Zingerman, Boris, et al.
Publicado: (2020) -
Bezafibrate for X-Linked Adrenoleukodystrophy
por: Engelen, Marc, et al.
Publicado: (2012)